• SENSEX 80,710.76
    -7.25 (--0.01%)
  • BANKNIFTY 54,114.55
    39.10 (+0.07%)
  • N S D L
    1,298.70 1,425.00(%)
  • Ola Electric
    59.38 39.58(%)
  • Netweb Technol.
    3,180.10 3,180.10(%)
  • Indus Towers
    341.75 444.45(%)
  • Vodafone Idea
    7.45 15.22(%)
  • Moschip Tech.
    258.25 279.00(%)
  • Godfrey Phillips
    11,150.00 11,462.00(%)
  • Vimta Labs
    902.85 902.85(%)
  • G M D C
    515.00 515.00(%)
  • Fiem Industries
    2,005.00 1,156.00(%)
  • One Mobikwik
    309.00 698.30(%)
  • Brainbees Solut.
    407.80 734.25(%)
  • Apollo Micro Sys
    298.65 88.10(%)
  • Avantel
    180.20 191.01(%)
  • Swiggy
    440.00 617.00(%)
  • TCS
    3,029.50 2,992.05(%)
  • Eternal Ltd
    334.40 334.40(%)
  • L&T Finance Ltd
    232.85 232.85(%)
  • Reliance Industr
    1,380.80 1,551.00(%)
  • Kross Ltd
    235.00 271.00(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Medicamen Biotech Ltd Pharmaceuticals - Indian - Formulations

  • Indian Private
  • BSE Code : 5905.0
  • ISIN : INE646B01010
350.40 4 (1.10%)
  • As on 07 Sep 2025 (EOD)

  • Today’s Low

    344.45

  • Today’s High

    352.10

  • Open

    349.70

  • Perv Close

    346.60

  • 52W Low

    341.70

  • 52W High

    630.00

Key Indicators

  • P/E(TTM)

    53.94

  • Mar.Cap (₹Cr.)

    475.24

  • Div & Yield %

    0.27

  • Book Value(₹)

    193.43

  • Debt-Equity Ratio

    1.10

  • AGM Date

    05-Sep-2025

  • EPS

    6.51

  • P/E Ratio

    53.94

Financials Ratios

  • Debt-Equity Ratio

    0.14

  • Mar.Cap (₹Cr.)

    475.24

  • RONW (%)

    4.74

  • ROCE (%)

    8.14

Score Board

  • Equity (₹ in Cr.)

    13.56

  • BV (₹)

    193.40

  • Sales( ₹ in Cr.)

    151.46

  • NP (in Cr.)

    9.45

  • NP Var(%)

    -29.0

  • Div%

    10.0

  • CPS (₹)

    12.10

  • EPS (₹)

    7.00

  • Traded Value (₹ in Lakhs)

    476.26

  • 52 Week High

    630.00

  • 52 Week Low

    341.70

  • Price BSE

    351.0

  • Price NSE

    350.00

  • Market Capital( in Cr.)

    476.26

  • P/C Ratio

    29.00

  • P/E Ratio

    50.40

  • Price Vs.BV

    7.00

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar
INCOME :            
Sales Turnover 172.39 137.88 115.45 110.15 117.34 122.60
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 172.39 137.88 115.45 110.15 117.34 122.60
Other Income 2.30 2.46 1.72 0.75 1.91 3.66
Stock Adjustments 13.32 10.30 3.34 -1.04 1.53 -1.39
Total Income 188.01 150.64 120.51 109.86 120.78 124.87
EXPENDITURE :            
Raw Materials 104.70 81.80 55.69 65.84 74.49 81.95
Power and Fuel Cost 7.12 5.67 5.86 2.68 2.90 2.11
Employee Cost 22.12 18.57 14.50 8.79 9.29 8.09
Other Manufacturing Expenses 10.24 8.70 9.60 7.37 9.10 5.95
Selling and Administration Expenses 12.42 6.65 7.50 3.94 4.43 5.30
Miscellaneous Expenses 1.87 2.18 1.52 0.46 0.54 0.35
Employee Benefit Expenses 22.12 18.57 14.50 8.79 9.29 8.09
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 158.46 123.56 94.69 89.08 100.75 103.75
Operating Profit 29.55 27.08 25.82 20.78 20.03 21.12
Interest 5.65 3.39 1.94 1.51 0.93 1.38
Gross Profit 23.90 23.69 23.88 19.27 19.10 19.74
Depreciation 7.01 6.35 5.77 2.52 2.50 2.21
Profit Before Tax 16.89 17.34 18.11 16.75 16.60 17.53
Current Tax 4.22 3.70 3.98 4.15 4.60 5.50
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax -0.63 -1.37 -0.78 0.12 -0.25 0.00
Reported Net Profit 13.30 15.00 14.91 12.49 12.26 12.03
Extraordinary Items 0.00 -0.01 0.00 0.00 -0.04 0.01
Adjusted Net Profit 13.30 15.01 14.91 12.49 12.30 12.02
Adjustment below Net Profit 0.00 0.09 0.00 0.00 0.00 0.00
P & L Balance brought forward 82.15 68.32 54.43 42.56 31.77 19.74
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 1.27 1.27 1.22 0.61 1.47 0.00
P & L Balance carried down 94.18 82.15 68.12 54.43 42.56 31.77
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 10.00 10.00 10.00 10.00 5.00 10.00
Dividend Per Share(Rs) 1.00 1.00 1.00 1.00 0.50 1.00
Earnings Per Share-Unit Curr 10.46 11.86 12.20 10.22 10.03 10.28
Earnings Per Share(Adj)-Unit Curr 10.46 11.86 12.20 10.22 10.03 10.28
Book Value 164.54 152.30 121.18 109.98 100.25 74.05
Book Value(Adj)-Unit Curr 164.54 152.30 121.18 109.98 100.25 74.05

Shareholding Pattern

  • Promoter Group

    40.46%

  • Public Share Holding

    59.54%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 5,487,095 40.46 5,487,095 1
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 0 0.00 0 0
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 5,487,095 40.46 5,487,095 1
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 7,000 0.05 7,000 1
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 629 0.00 629 2
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 87,421 0.64 87,421 2
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 95,050 0.70 95,050 5
2] Non Institution
Bodies Corporate 297,237 2.19 295,737 104
Clearing Members 0 0.00 0 0
Directors of their Relatives 202,813 1.50 202,813 1
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 363,717 2.68 363,717 2
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 60,175 0.44 59,975 157
Foreign Non Institution Other 1,939,995 14.30 1,939,995 2
Hindu Undivided Families 415,131 3.06 415,131 361
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 1,311,772 9.67 1,311,772 29
Individuals holding nominal share capital up to Rs. 1 lakh 2,961,042 21.83 2,919,222 10,129
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 340,761 2.51 340,761 3
Sub Total 7,980,670 58.84 7,937,150 10,802
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 13,562,815 100.00 13,519,295 10,808

Company Background

Medicamen Biotech LtdPharmaceuticals - Indian - Formulations

  • Medicamen Biotech Ltd
  • BSE Code : 5905.0
  • ISIN : INE646B01010

  • Incorporation Year

    1993

  • Registered Office

    1506 Chiranjiv Tower 43
    Nehru Place, New Delhi,
    New Delhi-110019

  • Telephone

    91-11-47589500

  • FAX

    91-11-26213081

  • Chairman

    Rahul Bishnoi

  • Managing Director

  • Company Secretary

    Parul Choudhary

  • Auditor

    Rai Qimat & Associates

  • Face Value

    10

  • Listing

    NSE

  • Registrar

    Link Intime India Pvt Ltd
    Narang Tower,
    44 Community Centre,Naraina Ind Area
    Mumbai - New Delhi-110028

Medicamen Biotech Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Medicamen Biotec 351.15 174.69 172.39 53.94 9.76
Abbott India 31,179.05 6,684.73 6,409.15 45.62 44.95
Astrazeneca Phar 9,088.15 1,756.92 1,716.29 123.92 32.94
P & G Health Ltd 6,465.40 944.52 934.17 35.70 40.23
Glaxosmi. Pharma 2,770.30 3,866.05 3,723.49 49.82 58.72
Cipla 1,553.30 20,029.57 19,044.85 23.21 21.40
Amrutanjan Healt 769.30 469.50 451.82 40.79 21.89
Guj. Themis Bio. 383.80 152.47 150.80 93.84 27.21
Fermenta Biotec. 334.60 442.21 430.53 11.10 17.61
Bliss GVS Pharma 156.00 703.42 667.20 23.32 9.16
Ambalal Sarabhai 32.39 19.33 4.04 16.96 2.10